Eyes on July 2, 2012: Forum Explores Path to EVMPD

From Shock to Action: Getting Ready for the EVMPD

As pharmaceutical companies recover from the shock caused by the announcement of the EudraVigilance Medicinal Product Dictionary (EVMPD) mandate, the race is on to ensure they're ready to meet the July 2, 2012, deadline. And with less than five months to go until EVMPD D-day, the mandate remains uppermost in the minds of regulatory affairs executives and their teams.

During an exclusive forum discussion, regulatory leaders at several of the top 10 pharma companies, along with subject-matter experts, discussed (1) how the mandate has affected their departments and their companies, (2) where the greatest challenges lie and (3) how they plan to proceed in the short, medium and long terms. Learn from those in the thick of the EVMPD requirement the how, why, where, what and where of one of the broadest-reaching regulatory changes in decades.

To read the contents of that informative EVMPD forum, register to download.